Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New Insights into the Implication of Epigenetic Alterations in the EMT of Triple Negative Breast Cancer
Noura Khaled, Yannick Bidet
Cancers (2019) Vol. 11, Iss. 4, pp. 559-559
Open Access | Times Cited: 112

Showing 1-25 of 112 citing articles:

Exosome-mediated siRNA delivery to suppress postoperative breast cancer metastasis
Liuwan Zhao, Chunyan Gu, Ye Gan, et al.
Journal of Controlled Release (2019) Vol. 318, pp. 1-15
Closed Access | Times Cited: 321
Roles of miRNA and IncRNA in triple-negative breast cancer
Juan Xu, Kangjing Wu, Qiaojun Jia, et al.
Journal of Zhejiang University SCIENCE B (2020) Vol. 21, Iss. 9, pp. 673-689
Open Access | Times Cited: 99
Epigenetic Alterations in Triple-Negative Breast Cancer—The Critical Role of Extracellular Matrix
Vasiliki Zolota, Vassiliki Tzelepi, Zoi Piperigkou, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 713-713
Open Access | Times Cited: 59
Challenges and Opportunities in Developing Targeted Therapies for Triple Negative Breast Cancer
Abygail G. Chapdelaine, Gongqin Sun
Biomolecules (2023) Vol. 13, Iss. 8, pp. 1207-1207
Open Access | Times Cited: 23
GAS5 lncRNA: A biomarker and therapeutic target in breast cancer
Lakshmi Thangavelu, Ehssan Moglad, Gaurav Gupta, et al.
Pathology - Research and Practice (2024) Vol. 260, pp. 155424-155424
Closed Access | Times Cited: 10
Triple-Negative Breast Cancer Progression and Drug Resistance in the Context of Epithelial–Mesenchymal Transition
Ewa Błaszczak, Paulina Miziak, Adrian Odrzywolski, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 228-228
Open Access | Times Cited: 1
Chronic stress promotes EMT-mediated metastasis through activation of STAT3 signaling pathway by miR-337-3p in breast cancer
Peixin Du, Hao Zeng, Yinan Xiao, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 9
Open Access | Times Cited: 61
Understanding Patterns of Brain Metastasis in Triple-Negative Breast Cancer and Exploring Potential Therapeutic Targets
Yan Lv, Xiao Ma, Yuxin Du, et al.
OncoTargets and Therapy (2021) Vol. Volume 14, pp. 589-607
Open Access | Times Cited: 50
Long noncoding RNAs in triple‐negative breast cancer: A new frontier in the regulation of tumorigenesis
Krishan Kumar Thakur, Aviral Kumar, Kishore Banik, et al.
Journal of Cellular Physiology (2021) Vol. 236, Iss. 12, pp. 7938-7965
Closed Access | Times Cited: 50
LncRNA SOX9-AS1 triggers a transcriptional program involved in lipid metabolic reprogramming, cell migration and invasion in triple-negative breast cancer
Mireya Cisneros-Villanueva, Marco Antonio Fonseca-Montaño, M. Rios-Romero, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Shikonin inhibits migration and invasion of triple-negative breast cancer cells by suppressing epithelial-mesenchymal transition via miR-17-5p/PTEN/Akt pathway
Chang Bao, Tao Liu, Ling-Bo Qian, et al.
Journal of Cancer (2020) Vol. 12, Iss. 1, pp. 76-88
Open Access | Times Cited: 44
DCST1-AS1 Promotes TGF-β-Induced Epithelial–Mesenchymal Transition and Enhances Chemoresistance in Triple-Negative Breast Cancer Cells via ANXA1
Li Tang, Yu‐Li Chen, Huanhuan Chen, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 43
The role of EMT-related lncRNA in the process of triple-negative breast cancer metastasis
Haomeng Zhang, Jiao Wang, Yulong Yin, et al.
Bioscience Reports (2021) Vol. 41, Iss. 2
Open Access | Times Cited: 33
Persistent Inflammatory Stimulation Drives the Conversion of MSCs to Inflammatory CAFs That Promote Pro-Metastatic Characteristics in Breast Cancer Cells
Linor Rubinstein-Achiasaf, Dina Morein, Hagar Ben-Yaakov, et al.
Cancers (2021) Vol. 13, Iss. 6, pp. 1472-1472
Open Access | Times Cited: 33
HDAC8 suppresses the epithelial phenotype and promotes EMT in chemotherapy-treated basal-like breast cancer
Garyfallia Pantelaiou‐Prokaki, Iga K. Mieczkowska, G. Schmídt, et al.
Clinical Epigenetics (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 25
Function and inhibition of DYRK1A: Emerging roles of treating multiple human diseases
Yuping Yang, Xiaoxiao Fan, Yongjian Liu, et al.
Biochemical Pharmacology (2023) Vol. 212, pp. 115521-115521
Closed Access | Times Cited: 14
CSCs in Breast Cancer—One Size Does Not Fit All: Therapeutic Advances in Targeting Heterogeneous Epithelial and Mesenchymal CSCs
Andrew Sulaiman, Sarah McGarry, Xianghui Han, et al.
Cancers (2019) Vol. 11, Iss. 8, pp. 1128-1128
Open Access | Times Cited: 36
Targeting IL-3Rα on tumor-derived endothelial cells blunts metastatic spread of triple-negative breast cancer via extracellular vesicle reprogramming
Tatiana Lopatina, Cristina Grange, Claudia Cavallari, et al.
Oncogenesis (2020) Vol. 9, Iss. 10
Open Access | Times Cited: 36
Breast Cancer Derived Extracellular Vesicles in Bone Metastasis Induction and Their Clinical Implications as Biomarkers
Simona Taverna, Ilaria Giusti, Sandra D’Ascenzo, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 10, pp. 3573-3573
Open Access | Times Cited: 34
Hindering the Synchronization Between miR-486-5p and H19 lncRNA by Hesperetin Halts Breast Cancer Aggressiveness Through Tuning ICAM-1
R. Abdallah, Aisha M. Elkhouly, R.A. Soliman, et al.
Anti-Cancer Agents in Medicinal Chemistry (2021) Vol. 22, Iss. 3, pp. 586-595
Closed Access | Times Cited: 30
G9a Knockdown Suppresses Cancer Aggressiveness by Facilitating Smad Protein Phosphorylation through Increasing BMP5 Expression in Luminal A Type Breast Cancer
Yunho Jin, Shinji Park, Soon-Yong Park, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 589-589
Open Access | Times Cited: 19
Current therapeutic approaches and promising perspectives of using bioengineered peptides in fighting chemoresistance in triple-negative breast cancer
Mandana Azari, Farbod Bahreini, Vladimir N. Uversky, et al.
Biochemical Pharmacology (2023) Vol. 210, pp. 115459-115459
Closed Access | Times Cited: 11
PVT1 affects EMT and cell proliferation and migration via regulating p21 in triple-negative breast cancer cells cultured with mature adipogenic medium
Lingli Wang, Ruirui Wang, Zi Ye, et al.
Acta Biochimica et Biophysica Sinica (2018) Vol. 50, Iss. 12, pp. 1211-1218
Open Access | Times Cited: 33
Knockdown of FAM64A suppresses proliferation and migration of breast cancer cells
Zhuocheng Yao, X.F. Steven Zheng, Sitong Lu, et al.
Breast Cancer (2019) Vol. 26, Iss. 6, pp. 835-845
Closed Access | Times Cited: 32
Triptonide effectively inhibits triple-negative breast cancer metastasis through concurrent degradation of Twist1 and Notch1 oncoproteins
Mengli Zhang, Mei Meng, Yuxi Liu, et al.
Breast Cancer Research (2021) Vol. 23, Iss. 1
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top